IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations
IDH 突变低级别(WHO II/III 级)星形细胞瘤可根据 CDKN2A、CDK4 和 PDGFRA 拷贝数变异进行风险分层
期刊:Brain Pathology
影响因子:5.8
doi:10.1111/bpa.12801
Rui Ryan Yang, Zhi-Feng Shi, Zhen-Yu Zhang, Aden Ka-Yin Chan, Abudumijiti Aibaidula, Wei-Wei Wang, Johnny Sheung Him Kwan, Wai Sang Poon, Hong Chen, Wen-Cai Li, Nellie Yuk-Fei Chung, Gopika Punchhi, William Ching-Yuen Chu, Ivan Sik-Hei Chan, Xian-Zhi Liu, Ying Mao, Kay Ka-Wai Li, Ho-Keung Ng